These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 21659624

  • 21. Safety and efficacy of vernakalant for the conversion of atrial fibrillation to sinus rhythm; a phase 3b randomized controlled trial.
    Beatch GN, Mangal B.
    BMC Cardiovasc Disord; 2016 May 28; 16():113. PubMed ID: 27233239
    [Abstract] [Full Text] [Related]

  • 22. Intravenous vernakalant: a review of its use in the management of recent-onset atrial fibrillation.
    Duggan ST, Scott LJ.
    Drugs; 2011 Jan 22; 71(2):237-52. PubMed ID: 21275448
    [Abstract] [Full Text] [Related]

  • 23. Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation: an update.
    Tsuji Y, Dobrev D.
    Vasc Health Risk Manag; 2013 Jan 22; 9():165-75. PubMed ID: 23637539
    [Abstract] [Full Text] [Related]

  • 24. Efficacy and safety of intravenous vernakalant for the rapid conversion of recent-onset atrial fibrillation: A meta-analysis.
    Akel T, Lafferty J.
    Ann Noninvasive Electrocardiol; 2018 May 22; 23(3):e12508. PubMed ID: 29105209
    [Abstract] [Full Text] [Related]

  • 25. Pharmacological cardioversion of atrial fibrillation with vernakalant: evidence in support of the ESC Guidelines.
    Savelieva I, Graydon R, Camm AJ.
    Europace; 2014 Feb 22; 16(2):162-73. PubMed ID: 24108230
    [Abstract] [Full Text] [Related]

  • 26. A new antiarrhythmic drug in the treatment of recent-onset atrial fibrillation: vernakalant.
    Vizzardi E, Salghetti F, Bonadei I, Gelsomino S, Lorusso R, D'Aloia A, Curnis A.
    Cardiovasc Ther; 2013 Oct 22; 31(5):e55-62. PubMed ID: 23398692
    [Abstract] [Full Text] [Related]

  • 27. Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial.
    Roy D, Pratt CM, Torp-Pedersen C, Wyse DG, Toft E, Juul-Moller S, Nielsen T, Rasmussen SL, Stiell IG, Coutu B, Ip JH, Pritchett EL, Camm AJ, Atrial Arrhythmia Conversion Trial Investigators.
    Circulation; 2008 Mar 25; 117(12):1518-25. PubMed ID: 18332267
    [Abstract] [Full Text] [Related]

  • 28. Use of intravenous vernakalant for atrial fibrillation conversion in the regular ward under only bedside monitoring.
    Manolis AS, Bethanis S, Metaxa S, Polytarchou K, Sakellaris N, Pyrros I.
    Hellenic J Cardiol; 2019 Mar 25; 60(1):54-56. PubMed ID: 29454598
    [No Abstract] [Full Text] [Related]

  • 29. Vernakalant: pharmacology electrophysiology, safety and efficacy.
    Naccarelli GV, Wolbrette DL, Samii S, Banchs JE, Penny-Peterson E, Stevenson R, Gonzalez MD.
    Drugs Today (Barc); 2008 May 25; 44(5):325-9. PubMed ID: 18548135
    [Abstract] [Full Text] [Related]

  • 30. Vernakalant for Rapid Cardioversion of Recent-Onset Atrial Fibrillation: Results from the SPECTRUM Study.
    Lévy S, Hartikainen J, Ritz B, Juhlin T, Carbajosa-Dalmau J, Domanovits H.
    Cardiovasc Drugs Ther; 2021 Apr 25; 35(2):283-292. PubMed ID: 33206300
    [Abstract] [Full Text] [Related]

  • 31. Systematic Review and Meta-analysis Appraising Efficacy and Safety of Vernakalant for Cardioversion of Recent-Onset Atrial Fibrillation.
    Ma W, Guo X, Wang Q, Sun G, Wang J.
    J Cardiovasc Pharmacol; 2020 Jul 25; 76(1):32-41. PubMed ID: 32251022
    [Abstract] [Full Text] [Related]

  • 32. Comparison of the in vivo hemodynamic effects of the antiarrhythmic agents vernakalant and flecainide in a rat hindlimb perfusion model.
    Allison B, Yang Y, Pourrier M, Gibson JK.
    J Cardiovasc Pharmacol; 2011 Apr 25; 57(4):463-8. PubMed ID: 21283020
    [Abstract] [Full Text] [Related]

  • 33. Efficacy and safety of vernakalant in patients with atrial flutter: a randomized, double-blind, placebo-controlled trial.
    Camm AJ, Toft E, Torp-Pedersen C, Vijayaraman P, Juul-Moller S, Ip J, Beatch GN, Dickinson G, Wyse DG, Scene 2 Investigators.
    Europace; 2012 Jun 25; 14(6):804-9. PubMed ID: 22291438
    [Abstract] [Full Text] [Related]

  • 34. Is vernakalant better or not, compared with other treatments for conversion of acute atrial fibrillation?
    Conde D.
    Int J Cardiol; 2013 Oct 30; 169(2):95-6. PubMed ID: 24071384
    [Abstract] [Full Text] [Related]

  • 35. Vernakalant: A novel agent for the termination of atrial fibrillation.
    Finnin M.
    Am J Health Syst Pharm; 2010 Jul 15; 67(14):1157-64. PubMed ID: 20592320
    [Abstract] [Full Text] [Related]

  • 36. Atrial selective effects of intravenously administered vernakalant in conscious beagle dogs.
    Bechard J, Pourrier M.
    J Cardiovasc Pharmacol; 2011 Jul 15; 58(1):49-55. PubMed ID: 21753258
    [Abstract] [Full Text] [Related]

  • 37. A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation.
    Roy D, Rowe BH, Stiell IG, Coutu B, Ip JH, Phaneuf D, Lee J, Vidaillet H, Dickinson G, Grant S, Ezrin AM, Beatch GN, CRAFT Investigators.
    J Am Coll Cardiol; 2004 Dec 21; 44(12):2355-61. PubMed ID: 15607398
    [Abstract] [Full Text] [Related]

  • 38. Novel agents for the acute conversion of atrial fibrillation: focus on vernakalant.
    Cialdella P, Pedicino D, Santangeli P.
    Recent Pat Cardiovasc Drug Discov; 2011 Jan 21; 6(1):1-8. PubMed ID: 21235460
    [Abstract] [Full Text] [Related]

  • 39. Predictors of successful cardioversion with vernakalant in patients with recent-onset atrial fibrillation.
    Mochalina N, Juhlin T, Öhlin B, Carlson J, Holmqvist F, Platonov PG.
    Ann Noninvasive Electrocardiol; 2015 Mar 21; 20(2):140-7. PubMed ID: 25040826
    [Abstract] [Full Text] [Related]

  • 40. Intravenous vernakalant in comparison with intravenous flecainide in the cardioversion of recent-onset atrial fibrillation.
    Pohjantähti-Maaroos H, Hyppölä H, Lekkala M, Sinisalo E, Heikkola A, Hartikainen J.
    Eur Heart J Acute Cardiovasc Care; 2019 Mar 21; 8(2):114-120. PubMed ID: 28849946
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.